Related Experiment Video

Updated: May 25, 2025

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
11:34

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

6.6K

RNA-binding proteins as therapeutic targets in cancer

Jennifer Jungfleisch1, Fátima Gebauer1,2

  • 1Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.

RNA Biology
|February 27, 2025
PubMed

Insights

RNA-binding proteins (RBPs) are key cancer regulators. Targeting RBPs like eIF4F, FTO, SF3B1, RBM39, and nucleolin offers promising new cancer therapies, despite challenges in specificity and network complexity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • RNA-binding proteins (RBPs) significantly influence cancer progression by regulating gene expression.
  • RBPs are implicated in multiple hallmarks of cancer, making them attractive therapeutic targets.
  • Targeting RBPs presents a novel strategy for developing next-generation anti-cancer therapies.

Purpose of the Study:

  • To review the current landscape of RBP-targeted cancer treatments.
  • To highlight specific examples of RBPs being targeted in cancer therapy.
  • To discuss the challenges and future potential of RBP-based cancer therapeutics.

Main Methods:

  • Literature review focusing on RBP-targeted cancer therapies.
  • Analysis of five key RBPs: eIF4F, FTO, SF3B1, RBM39, and nucleolin.
  • Discussion of diverse targeting strategies and associated challenges.

Main Results:

  • RBPs regulate gene expression critical for tumorigenesis.
  • Five specific RBPs (eIF4F, FTO, SF3B1, RBM39, nucleolin) are discussed as therapeutic targets.
  • Current targeting approaches are diverse, but challenges like network complexity and off-target effects exist.

Conclusions:

  • RBPs are crucial regulators in cancer, offering significant therapeutic potential.
  • Further development of specific targeting methods is needed to overcome challenges.
  • RBPs are poised to play a vital role in future cancer treatment strategies.
Keywords:
ASORNA-binding proteinsSMIaptamercancermolecular gluetherapeutic targets

More Related Videos

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.4K
Detection of RNA-binding Proteins by In Vitro RNA Pull-down in Adipocyte Culture10:34

Detection of RNA-binding Proteins by In Vitro RNA Pull-down in Adipocyte Culture

Published on: July 22, 2016

23.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.3K
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.0K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K